(Y51.6) Alpha-adrenoreceptor antagonists, not elsewhere classified

More details coming soon

Icon
17 073 in individuals diagnosis alpha-adrenoreceptor antagonists, not elsewhere classified confirmed
Icon
507 deaths with diagnosis alpha-adrenoreceptor antagonists, not elsewhere classified
Icon
3% mortality rate associated with the disease alpha-adrenoreceptor antagonists, not elsewhere classified

Diagnosis alpha-adrenoreceptor antagonists, not elsewhere classified is diagnosed Men are 43.77% more likely than Women

12 273

Men receive the diagnosis alpha-adrenoreceptor antagonists, not elsewhere classified

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800

Women receive the diagnosis alpha-adrenoreceptor antagonists, not elsewhere classified

507 (10.6 %)

Died from this diagnosis.

Risk Group for the Disease alpha-adrenoreceptor antagonists, not elsewhere classified - Men aged 70-74 and Women aged 50-54

Icon
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Icon
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
Icon
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84

Disease Features alpha-adrenoreceptor antagonists, not elsewhere classified

Icon
Absence or low individual and public risk
Icon

Alpha-adrenoreceptor antagonists, not elsewhere classified - what does this mean

Alpha-adrenoreceptor antagonists, not elsewhere classified are a class of drugs that act as antagonists on alpha receptors in the body. these drugs block the action of the hormone epinephrine, which is responsible for the body's fight-or-flight response, and can be used to treat conditions such as hypertension, angina, and urinary incontinence.

What happens during the disease - alpha-adrenoreceptor antagonists, not elsewhere classified

More details coming soon

Clinical Pattern

More details coming soon

How does a doctor diagnose

More details coming soon

Treatment and Medical Assistance

More details coming soon
Icon
8 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Alpha-adrenoreceptor antagonists, not elsewhere classified - Prevention

Alpha-adrenoreceptor antagonists, not elsewhere classified can be prevented by avoiding exposure to environmental toxins, maintaining a healthy lifestyle, and avoiding activities that may cause physical injury. additionally, regular physical activity, healthy diet, and stress management can help to reduce the risk of developing this condition.